303 related articles for article (PubMed ID: 10364319)
41. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.
Salat D; Liefke R; Wiedenmann J; Borggrefe T; Oswald F
Mol Cell Biol; 2008 May; 28(10):3502-12. PubMed ID: 18332109
[TBL] [Abstract][Full Text] [Related]
42. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway.
Kao HY; Ordentlich P; Koyano-Nakagawa N; Tang Z; Downes M; Kintner CR; Evans RM; Kadesch T
Genes Dev; 1998 Aug; 12(15):2269-77. PubMed ID: 9694793
[TBL] [Abstract][Full Text] [Related]
43. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B.
Yang L; Mei Q; Zielinska-Kwiatkowska A; Matsui Y; Blackburn ML; Benedetti D; Krumm AA; Taborsky GJ; Chansky HA
Biochem J; 2003 Feb; 369(Pt 3):651-7. PubMed ID: 12398767
[TBL] [Abstract][Full Text] [Related]
44. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
Ling PD; Rawlins DR; Hayward SD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
[TBL] [Abstract][Full Text] [Related]
45. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.
McClellan MJ; Wood CD; Ojeniyi O; Cooper TJ; Kanhere A; Arvey A; Webb HM; Palermo RD; Harth-Hertle ML; Kempkes B; Jenner RG; West MJ
PLoS Pathog; 2013 Sep; 9(9):e1003636. PubMed ID: 24068937
[TBL] [Abstract][Full Text] [Related]
46. Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1.
Kang JE; Kim MH; Lee JA; Park H; Min-Nyung L; Auh CK; Hur MW
Cell Physiol Biochem; 2005; 16(1-3):23-30. PubMed ID: 16121030
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
[TBL] [Abstract][Full Text] [Related]
48. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
Lin J; Johannsen E; Robertson E; Kieff E
J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
[TBL] [Abstract][Full Text] [Related]
50. SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway.
Oswald F; Kostezka U; Astrahantseff K; Bourteele S; Dillinger K; Zechner U; Ludwig L; Wilda M; Hameister H; Knöchel W; Liptay S; Schmid RM
EMBO J; 2002 Oct; 21(20):5417-26. PubMed ID: 12374742
[TBL] [Abstract][Full Text] [Related]
51. Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain.
Ding Z; Gillespie LL; Paterno GD
Mol Cell Biol; 2003 Jan; 23(1):250-8. PubMed ID: 12482978
[TBL] [Abstract][Full Text] [Related]
52. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter.
Mehra-Chaudhary R; Matsui H; Raghow R
Biochem J; 2001 Jan; 353(Pt 1):13-22. PubMed ID: 11115394
[TBL] [Abstract][Full Text] [Related]
53. EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.
Pei Y; Banerjee S; Sun Z; Jha HC; Saha A; Robertson ES
PLoS Pathog; 2016 Aug; 12(8):e1005844. PubMed ID: 27548379
[TBL] [Abstract][Full Text] [Related]
54. Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene.
Clem BF; Clark BJ
Mol Endocrinol; 2006 Jan; 20(1):100-13. PubMed ID: 16109738
[TBL] [Abstract][Full Text] [Related]
55. Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.
Lu H; Pise-Masison CA; Linton R; Park HU; Schiltz RL; Sartorelli V; Brady JN
J Virol; 2004 Jul; 78(13):6735-43. PubMed ID: 15194748
[TBL] [Abstract][Full Text] [Related]
56. Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.
Touitou R; Hickabottom M; Parker G; Crook T; Allday MJ
J Virol; 2001 Aug; 75(16):7749-55. PubMed ID: 11462050
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.
Calderwood MA; Lee S; Holthaus AM; Blacklow SC; Kieff E; Johannsen E
Virology; 2011 May; 414(1):19-25. PubMed ID: 21440926
[TBL] [Abstract][Full Text] [Related]
58. Histone deacetylase activity is required for full transcriptional repression by mSin3A.
Hassig CA; Fleischer TC; Billin AN; Schreiber SL; Ayer DE
Cell; 1997 May; 89(3):341-7. PubMed ID: 9150133
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
Nan X; Ng HH; Johnson CA; Laherty CD; Turner BM; Eisenman RN; Bird A
Nature; 1998 May; 393(6683):386-9. PubMed ID: 9620804
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.
Subramanian C; Hasan S; Rowe M; Hottiger M; Orre R; Robertson ES
J Virol; 2002 May; 76(10):4699-708. PubMed ID: 11967287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
